CCL2 and non-Hodgkin lymphoma: In addition, pre-treatment plasma levels of biomarkers of immune activation/inflammation (sTNF-RII, sCD25), microbial translocation (sCD14), and/or macrophage activation (BAFF/BLyS and CCL2/MCP-1) are associated with overall survival and progression-free survival of AIDS-NHL patients (39).